参考文献/References:
[1]Bachert C,Gevaert P,Hellings P.Biotherapeutics in chronic rhinosinusitis with and without nasal polyps[J].The Journal of Allergy and Clinical Immunology: In Practice,2017,5(6):1512-1516.[2]Howard BE,Lal D.Oral steroid therapy in chronic rhinosinusitis with and without nasal polyposis[J].Current Allergy and Asthma Reports,2013,13(2):236-243.[3]Stevens WW,Lee RJ,Schleimer RP,et al.Chronic rhinosinusitis pathogenesis[J].Journal of Allergy and Clinical Immunology,2015,136(6):1442-1453.[4]Wang X,Zhao C,Ji W,et al.Relationship of TLR2, TLR4 and tissue remodeling in chronic rhinosinusitis[J].International Journal of Clinical and Experimental Pathology,2015,8(2):1199.[5]Lind H,Joergensen G,Lange B,et al.Efficacy of ESS in chronic rhinosinusitis with and without nasal polyposis: a Danish cohort study[J].European Archives of Oto-Rhino-Laryngology,2016,273(4):911-919.[6]Singh P,Mehta R,Agarwal S,et al.Bacterial biofilm on the sinus mucosa of healthy subjects and patients with chronic rhinosinusitis (with or without nasal polyposis)[J].The Journal of Laryngology & Otology,2015,129(1):46-49.[7]Zhang QI,Wang CS,Han DM,et al.Differential expression of Toll-like receptor pathway genes in chronic rhinosinusitis with or without nasal polyps[J].Acta Otolaryngol,2013,133(2):165-173.[8]王彤,臧洪瑞,李云川,等.MAPK信号通路在慢性鼻-鼻窦炎伴鼻息肉和不伴鼻息肉的黏膜上皮修复机制中的作用[J].临床耳鼻咽喉头颈外科杂志,2018,32(21):17-21.[9]Yang Y,Zhang N,Crombruggen KV,et al.Differential Expression and Release of Activin A and Follistatin in Chronic Rhinosinusitis with and without Nasal Polyps[J].PLoS One,2015,10(6):e0128564-e0128578.[10]Poetker DM.Oral corticosteroids in the management of chronic rhinosinusitis with and without nasal polyps:Risks and benefits[J].American Journal of Rhinology & Allergy,2015,29(5):339-342.[11]K?觟nig K,Klemens C,Haack M,et al.Cytokine patterns in nasal secretion of non-atopic patients distinguish between chronic rhinosinusitis with or without nasal polys[J].Allergy, Asthma & Clinical Immunology,2016,12(1):19.[12]Liu Q,Lu X,Bo M,et al.The microbiology of chronic rhinosinusitis with and without nasal polyps[J].Acta Otolaryngol,2014,134(12):1251-1258.[13]Liu C,Zheng M,He F,et al.Role of exhaled nasal nitric oxide in distinguishing between chronic rhinosinusitis with and without nasal polyps[J].American Journal of Rhinology & Allergy,2017,31(6):389-394.[14]黄耀光.HMGB1/PTEN/TLR4/NF-κB在慢性鼻-鼻窦炎的表达及作用[D].广州:暨南大学,2016.[15]Hirschberg A,Kiss M,Kadocsa E,et al.Different activations of toll-like receptors and antimicrobial peptides in chronic rhinosinusitis with or without nasal polyposis[J].European Archives of Oto-Rhino-Laryngology,2016,273(7):1779-1788.[16]Kaczmarek M,Banaszewski J,Leszczyńska M,et al.High frequency of macrophages expressing elevated level of CD80, PD-Ls and TLR1 in nasal polyps of CRS patients[J].Immunobiology,2019,224(1):154-162.[17]华丽,覃莉,岳海英,等.EGFR和KRAS基因状态对肺癌脑转移放疗敏感性的影响[J].东南大学学报(医学版),2016,35(6):947-951.[18]林甦,黄敬之.玉屏风散对变应性鼻炎模型大鼠TLR4/NF-κB信号通路的影响[J].中国中医药信息杂志,2018,25(12):53-57.[19]Wang M,Ye T,Liang N,et al.Differing roles for TGF-β/Smad signaling in osteitis in chronic rhinosinusitis with and without nasal polyps[J].American Journal of Rhinology & Allergy,2015,29(5):e152-e159.[20]Ozturan A,Eyigor H,Eyigor M,et al.The role of IL-25 and IL-33 in chronic rhinosinusitis with or without nasal polyps[J].European Archives of Oto-Rhino-Laryngology,2017,274(1):283-288.[21]胡琛,梁晨阳,周维国.炎症介导TLR4/NF-kB通路在过敏性鼻炎患者中的表达和作用[J].标记免疫分析与临床,2018(6):788-790,838.[22]Greguric T,Trkulja V,Baudoin T,et al.Differences in the Sino-Nasal Outcome Test 22 and visual analog scale symptom scores in chronic rhinosinusitis with and without nasal polyps[J].American Journal of Rhinology&Allergy,2016,30(2):107-112.